Fennec Pharmaceuticals (FENC) Total Current Liabilities (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Total Current Liabilities of $10.5 million for Q4 2025, up 52.02% year-on-year from $6.9 million in Q4 2024, and up 7.16% on a QoQ basis from $9.8 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Total Current Liabilities data on file, last reported at $10.5 million in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities rose 52.02% year-over-year to $10.5 million; the trailing twelve-month figure through Dec 2025 stood at $10.5 million (up 52.02% YoY), and the FY2025 full-year result was $10.5 million, up 52.02% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $10.5 million, up from $9.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $10.5 million in Q4 2025 and bottomed at $848000.0 in Q2 2021.
- The 5-year median for Total Current Liabilities is $4.3 million (2022), against an average of $5.4 million.
- The widest annual swing landed in 2021, when Total Current Liabilities slumped 73.42%; it then jumped 258.14% in 2022.
- A 5-year view of Total Current Liabilities shows it stood at $1.7 million in 2021, then soared by 178.66% to $4.6 million in 2022, then soared by 63.88% to $7.6 million in 2023, then declined by 8.39% to $6.9 million in 2024, then surged by 52.02% to $10.5 million in 2025.
- The last three Total Current Liabilities figures came in at $10.5 million (Q4 2025), $9.8 million (Q3 2025), and $8.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 10.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.52 Mn |
| Sep 30, 2025 | 9.82 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 8.37 Mn |
| Dec 31, 2024 | 6.92 Mn |
| Sep 30, 2024 | 7.44 Mn |
| Jun 30, 2024 | 7.75 Mn |
| Mar 31, 2024 | 9.84 Mn |
| Dec 31, 2023 | 7.55 Mn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 4.02 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Jun 30, 2021 | 848,000.00 |
| Mar 31, 2021 | 2.89 Mn |
| Dec 31, 2020 | 2.35 Mn |
| Sep 30, 2020 | 2.89 Mn |
| Jun 30, 2020 | 3.19 Mn |
| Mar 31, 2020 | 1.91 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Sep 30, 2019 | 905,000.00 |
| Jun 30, 2019 | 1.35 Mn |
| Mar 31, 2019 | 1.45 Mn |
| Dec 31, 2018 | 1.64 Mn |
| Sep 30, 2018 | 2.08 Mn |
| Jun 30, 2018 | 847,000.00 |
| Mar 31, 2018 | 1.17 Mn |
| Dec 31, 2017 | 1.64 Mn |
| Sep 30, 2017 | 1.03 Mn |
| Jun 30, 2017 | 580,000.00 |
| Mar 31, 2017 | 427,000.00 |
| Dec 31, 2016 | 402,000.00 |
| Sep 30, 2016 | 360,000.00 |
| Jun 30, 2016 | 451,000.00 |
| Mar 31, 2016 | 345,000.00 |
| Dec 31, 2015 | 471,000.00 |
| Sep 30, 2015 | 431,000.00 |
| Jun 30, 2015 | 759,000.00 |
| Mar 31, 2015 | 1.12 Mn |
| Dec 31, 2014 | 1.76 Mn |
| Sep 30, 2014 | 3.90 Mn |
| Jun 30, 2014 | 5.71 Mn |
| Mar 31, 2014 | 5.73 Mn |
| Dec 31, 2013 | 3.21 Mn |
| Mar 31, 2013 | 11.00 Mn |
| Dec 31, 2012 | 7.32 Mn |
| Dec 31, 2011 | 5.47 Mn |
| Dec 31, 2010 | 10.92 Mn |